Advertisement
Advertisement

DYN

DYN logo

Dyne Therapeutics, Inc. Common Stock

16.68
USD
Sponsored
+0.26
+1.60%
Jan 16, 16:00 UTC -5
Closed
exchange

After-Market

16.70

+0.02
+0.13%

DYN Earnings Reports

Positive Surprise Ratio

DYN beat 7 of 21 last estimates.

33%

Next Report

Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/
-$0.82
Implied change from Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q1 25 (Revenue/ EPS)
--
/
-21.90%

Dyne Therapeutics, Inc. Common Stock earnings per share and revenue

On Jan 12, 2026, DYN reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.77 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.41% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 9 analysts forecast an EPS of -0.82 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q4 2025, Dyne Therapeutics, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
The stock price moved down -2.41%, changed from $17.46 before the earnings release to $17.04 the day after.
The next earning report is scheduled for May 06, 2026.
Based on 9 analysts, Dyne Therapeutics, Inc. Common Stock is expected to report EPS of -$0.82 and revenue of -- for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement